- BMRN -1.62%
BioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Yahoo Finance · 4 days ago
Open | 84.80 |
High | 84.80 |
Low | 82.32 |
Mkt Cap | 15.65B |
P/E (TTM) | 77.77 |
Div & Yield | N/A & N/A |
Prev. Close | 83.80 |
52 Wk. Low | 76.02 |
52 Wk. High | 99.56 |
Related stocks
American company
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 648.83M | 8.80% ▲ |
Net Income | 88.66M | 74.40% ▲ |
Diluted EPS | 0.46 | 72.20% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.35 | - |
Q1 2024 | $0.34 | $0.46 |
Q4 2023 | $0.23 | $0.11 |
S&P 500^GSPC | 5,127.79+63.59 (+1.26%) |
Dow 30^DJI | 38,675.68+450.02 (+1.18%) |
Nasdaq^IXIC | 16,156.33+315.37 (+1.99%) |
16.47+29.08% | |
Bitcoin USDBTC-USD | 62,848.55+6.66% |
74.80-5.84% |